Matches in SemOpenAlex for { <https://semopenalex.org/work/W3035556978> ?p ?o ?g. }
- W3035556978 endingPage "3008" @default.
- W3035556978 startingPage "3000" @default.
- W3035556978 abstract "Pancreatic cancer is highly malignant and has a five-year survival rate of 5% due to an early lymph node, nerve, and vascular metastasis. Integrin α3β1 (also called very late antigen-3, VLA-3) is overexpressed in many tumors and plays a vital role in tumor formation, recurrence, and metastasis. In this study, we developed a 68Ga-radiolabeled peptide tracer targeting the α3 unit of VLA-3 and evaluated its potential application in positron emission computed tomography (PET) imaging of pancreatic cancer. NOTA-CK11 was prepared by solid-phase synthesis and successfully radiolabeled with 68Ga with greater than 99% radiochemical purity and a specific activity of 37 ± 5 MBq/nmol (n = 5). The expression level of integrin α3 in three human pancreatic cancer cells was evaluated with the order of SW1990, BXPC-3, and PANC-1 from high to low, while the expression level of integrin β1 was relatively close. When SW1990 cells with the highest expression level of VLA-3 were stained with FITC–CK11, strong fluorescence was observed by flow cytometry and under a laser confocal microscope. However, no significant fluorescence was observed in the blocking group when treated with excessive CK11. 68Ga-NOTA-CK11 showed significant radioactivity accumulation in SW1990 cells and was blocked by CK11 successfully. Subsequent small-animal PET imaging and biodistribution studies in mice bearing SW1990 xenografts confirmed its high tumor uptake with a good tumor-to-blood ratio and tumor-to-muscle ratio (2.45 ± 0.31 and 3.65 ± 0.33, respectively) at 1 h post injection of the probe. In summary, we successfully developed a peptide-based imaging agent, 68Ga-NOTA-CK11, that showed a strong binding affinity with VLA-3 and good target specificity for SW1990 cells and xenografted pancreatic tumor, rending it a promising radiotracer for PET imaging of VLA-3 expression in pancreatic cancer." @default.
- W3035556978 created "2020-06-19" @default.
- W3035556978 creator A5018073672 @default.
- W3035556978 creator A5019206637 @default.
- W3035556978 creator A5021479188 @default.
- W3035556978 creator A5032600383 @default.
- W3035556978 creator A5034284994 @default.
- W3035556978 creator A5043774051 @default.
- W3035556978 creator A5057112106 @default.
- W3035556978 creator A5058133350 @default.
- W3035556978 creator A5067881552 @default.
- W3035556978 creator A5080642996 @default.
- W3035556978 creator A5086381025 @default.
- W3035556978 date "2020-06-16" @default.
- W3035556978 modified "2023-10-02" @default.
- W3035556978 title "Synthesis and Preclinical Evaluation of a <sup>68</sup>Ga-Radiolabeled Peptide Targeting Very Late Antigen-3 for PET Imaging of Pancreatic Cancer" @default.
- W3035556978 cites W11939915 @default.
- W3035556978 cites W1212651875 @default.
- W3035556978 cites W1974651044 @default.
- W3035556978 cites W1982966572 @default.
- W3035556978 cites W2038465612 @default.
- W3035556978 cites W2041914114 @default.
- W3035556978 cites W2047130286 @default.
- W3035556978 cites W2051057004 @default.
- W3035556978 cites W2054661131 @default.
- W3035556978 cites W2055276888 @default.
- W3035556978 cites W2062571114 @default.
- W3035556978 cites W2075965099 @default.
- W3035556978 cites W2083916521 @default.
- W3035556978 cites W2092608399 @default.
- W3035556978 cites W2122967978 @default.
- W3035556978 cites W2141391002 @default.
- W3035556978 cites W2147971089 @default.
- W3035556978 cites W2157834399 @default.
- W3035556978 cites W2158164867 @default.
- W3035556978 cites W2292733418 @default.
- W3035556978 cites W2297782322 @default.
- W3035556978 cites W2328694799 @default.
- W3035556978 cites W2406825328 @default.
- W3035556978 cites W2414450839 @default.
- W3035556978 cites W2527231434 @default.
- W3035556978 cites W2554987853 @default.
- W3035556978 cites W2602879726 @default.
- W3035556978 cites W2770438853 @default.
- W3035556978 cites W2795159517 @default.
- W3035556978 cites W2800224370 @default.
- W3035556978 cites W2808307319 @default.
- W3035556978 cites W2891594311 @default.
- W3035556978 cites W2891822820 @default.
- W3035556978 cites W2914925401 @default.
- W3035556978 cites W2953307605 @default.
- W3035556978 cites W2991406598 @default.
- W3035556978 cites W2994415808 @default.
- W3035556978 cites W2995755583 @default.
- W3035556978 doi "https://doi.org/10.1021/acs.molpharmaceut.0c00416" @default.
- W3035556978 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32544337" @default.
- W3035556978 hasPublicationYear "2020" @default.
- W3035556978 type Work @default.
- W3035556978 sameAs 3035556978 @default.
- W3035556978 citedByCount "11" @default.
- W3035556978 countsByYear W30355569782021 @default.
- W3035556978 countsByYear W30355569782022 @default.
- W3035556978 countsByYear W30355569782023 @default.
- W3035556978 crossrefType "journal-article" @default.
- W3035556978 hasAuthorship W3035556978A5018073672 @default.
- W3035556978 hasAuthorship W3035556978A5019206637 @default.
- W3035556978 hasAuthorship W3035556978A5021479188 @default.
- W3035556978 hasAuthorship W3035556978A5032600383 @default.
- W3035556978 hasAuthorship W3035556978A5034284994 @default.
- W3035556978 hasAuthorship W3035556978A5043774051 @default.
- W3035556978 hasAuthorship W3035556978A5057112106 @default.
- W3035556978 hasAuthorship W3035556978A5058133350 @default.
- W3035556978 hasAuthorship W3035556978A5067881552 @default.
- W3035556978 hasAuthorship W3035556978A5080642996 @default.
- W3035556978 hasAuthorship W3035556978A5086381025 @default.
- W3035556978 hasConcept C121332964 @default.
- W3035556978 hasConcept C121608353 @default.
- W3035556978 hasConcept C126322002 @default.
- W3035556978 hasConcept C142724271 @default.
- W3035556978 hasConcept C147483822 @default.
- W3035556978 hasConcept C150903083 @default.
- W3035556978 hasConcept C185592680 @default.
- W3035556978 hasConcept C202751555 @default.
- W3035556978 hasConcept C203014093 @default.
- W3035556978 hasConcept C207001950 @default.
- W3035556978 hasConcept C2775842073 @default.
- W3035556978 hasConcept C2777807558 @default.
- W3035556978 hasConcept C2778172261 @default.
- W3035556978 hasConcept C2778764654 @default.
- W3035556978 hasConcept C2779013556 @default.
- W3035556978 hasConcept C2780210213 @default.
- W3035556978 hasConcept C2780849966 @default.
- W3035556978 hasConcept C2989005 @default.
- W3035556978 hasConcept C502942594 @default.
- W3035556978 hasConcept C553184892 @default.
- W3035556978 hasConcept C55493867 @default.
- W3035556978 hasConcept C57477423 @default.
- W3035556978 hasConcept C62520636 @default.